Gold (XAU/USD) witnessed technical selling at the long-held support now resistance of $1850 on Thursday, finishing the day with modest losses at around $1835. On Friday, the key $1850 barrier is set to limit XAU/USD bulls amid US stimulus deadlock.
“Brexit and US stimulus deadlock offset the optimism over the covid vaccine progress. The US FDA voted overwhelmingly to recommend the emergency use of Pfizer’s vaccine, although the authorization will take place in the coming days. Meanwhile, the persistent growth in the COVID-19 cases globally remains a cause for the market’s concern ahead of the US PPI and Michigan Consumer Sentiment data.”
“Gold wavers in an ascending triangle formation with a convincing break below the rising trendline support of $1833 to validate the pattern. The bears could then look to test the measured target at $1808.
“The bearish 50-HMA is likely to offer immediate resistance at $1842, above which the $1850 level will get challenged. That level is the confluence of the horizontal 100-HMA and trendline resistance. A daily closing above the $1850 hurdle is needed to negate the near-term bearish bias.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.